Zentalis Pharmaceuticals (ZNTL) Shares Outstanding (2019 - 2026)

Zentalis Pharmaceuticals' Shares Outstanding history runs 8 years deep, the most recent figure standing at $71.2 million for Q1 2026.

• In Q1 2026, Shares Outstanding fell 1.1% year-over-year to $71.2 million; the TTM figure through Mar 2026 stood at $71.2 million (down 1.1% YoY), while the FY2025 annual figure was $69.1 million, down 3.08% from the prior year.
• Shares Outstanding was $71.2 million for Q1 2026 at Zentalis Pharmaceuticals, up from $69.1 million in the prior quarter.
• In the past five years, Shares Outstanding ranged from a high of $72.2 million in Q3 2025 to a low of $45.6 million in Q1 2022.
• Historically, Shares Outstanding has averaged $66.6 million across 5 years, with a median of $70.8 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Shares Outstanding soared 37.88% in 2022, then decreased 3.08% in 2025.
• A 5-year view of Shares Outstanding shows it stood at $59.3 million in 2022, then gained by 19.38% to $70.8 million in 2023, then climbed by 0.73% to $71.3 million in 2024, then decreased by 3.08% to $69.1 million in 2025, then increased by 3.0% to $71.2 million in 2026.
• The last three Shares Outstanding figures came in at $71.2 million (Q1 2026), $69.1 million (Q4 2025), and $72.2 million (Q3 2025), per Business Quant data.